194 related articles for article (PubMed ID: 26108691)
1. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
[TBL] [Abstract][Full Text] [Related]
2. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
[TBL] [Abstract][Full Text] [Related]
3. TLX1-induced T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Ferrando AA
Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
[TBL] [Abstract][Full Text] [Related]
4. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
[TBL] [Abstract][Full Text] [Related]
5. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.
Rakowski LA; Lehotzky EA; Chiang MY
PLoS One; 2011 Feb; 6(2):e16761. PubMed ID: 21326611
[TBL] [Abstract][Full Text] [Related]
6. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
[TBL] [Abstract][Full Text] [Related]
7. The TLX1 oncogene drives aneuploidy in T cell transformation.
De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
[TBL] [Abstract][Full Text] [Related]
8. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.
Zweier-Renn LA; Hawley TS; Burkett S; Ramezani A; Riz I; Adler RL; Hickstein DD; Hawley RG
Genes Chromosomes Cancer; 2010 Feb; 49(2):119-31. PubMed ID: 19862821
[TBL] [Abstract][Full Text] [Related]
10. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
[TBL] [Abstract][Full Text] [Related]
11. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
[TBL] [Abstract][Full Text] [Related]
12. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
13. The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells.
Heidari M; Rice KL; Phillips JK; Kees UR; Greene WK
Leukemia; 2006 Feb; 20(2):304-12. PubMed ID: 16357834
[TBL] [Abstract][Full Text] [Related]
14. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
Asnafi V; Ferrier P
Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
[No Abstract] [Full Text] [Related]
15. Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?
Goldshtein A; Berger M
Crit Rev Oncog; 2014; 19(5):399-404. PubMed ID: 25404153
[TBL] [Abstract][Full Text] [Related]
16. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models.
Loontiens S; Vanhauwaert S; Depestel L; Dewyn G; Van Loocke W; Moore FE; Garcia EG; Batchelor L; Borga C; Squiban B; Malone-Perez M; Volders PJ; Olexiouk V; Van Vlierberghe P; Langenau DM; Frazer JK; Durinck K; Speleman F
Leukemia; 2020 Dec; 34(12):3398-3403. PubMed ID: 32591643
[No Abstract] [Full Text] [Related]
17. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
Verboom K; Van Loocke W; Volders PJ; Decaesteker B; Cobos FA; Bornschein S; de Bock CE; Atak ZK; Clappier E; Aerts S; Cools J; Soulier J; Taghon T; Van Vlierberghe P; Vandesompele J; Speleman F; Durinck K
Haematologica; 2018 Dec; 103(12):e585-e589. PubMed ID: 29954933
[No Abstract] [Full Text] [Related]
18. PHF6 mutations in T-cell acute lymphoblastic leukemia.
Van Vlierberghe P; Palomero T; Khiabanian H; Van der Meulen J; Castillo M; Van Roy N; De Moerloose B; Philippé J; González-García S; Toribio ML; Taghon T; Zuurbier L; Cauwelier B; Harrison CJ; Schwab C; Pisecker M; Strehl S; Langerak AW; Gecz J; Sonneveld E; Pieters R; Paietta E; Rowe JM; Wiernik PH; Benoit Y; Soulier J; Poppe B; Yao X; Cordon-Cardo C; Meijerink J; Rabadan R; Speleman F; Ferrando A
Nat Genet; 2010 Apr; 42(4):338-42. PubMed ID: 20228800
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
[TBL] [Abstract][Full Text] [Related]
20. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
